Investor alert: law offices of howard g. smith announces investigation of acelrx pharmaceuticals, inc. (acrx) on behalf of investors

Bensalem, pa.--(business wire)---- $acrx #classaction--law offices of howard g. smith announces an investigation on behalf of acelrx pharmaceuticals, inc. (“acelrx” or the “company”) (nasdaq: acrx) investors concerning the company's possible violations of federal securities laws. acelrx is a pharmaceutical company that develops therapies for the treatment of acute pain. one of its lead product candidates is dsuvia, which has been approved by the u.s. food and drug administration (“fda”) for the management of acute pa
ACRX Ratings Summary
ACRX Quant Ranking